归巢关联细胞黏附分子(HCAM)多克隆抗体

Polyclonal Antibody to Homing Associated Cell Adhesion Molecule (HCAM)

CDW44; CD44; CSPG8; ECMR-III; HCELL; IN; LHR; MC56; MDU2; MDU3; MIC4; MUTCH-I; Pgp1; Hematopoietic Cell E- And L-Selectin Ligand; Chondroitin Sulfate Proteoglycan 8

  • 归巢关联细胞黏附分子(HCAM)多克隆抗体 产品包装(模拟)
  • 归巢关联细胞黏附分子(HCAM)多克隆抗体 产品包装(模拟)
  • 归巢关联细胞黏附分子(HCAM)多克隆抗体 DAB staining on IHC-P;
    Sample: Mouse Lung Tissue
    Primary Ab: 10µg/ml Rabbit Anti-Mouse HCAM Antibody
    Control: Used PBS instead of primary antibody
    Second Ab: 2μg/ml HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
    (Catalog: SAA544Rb19)
  • 归巢关联细胞黏附分子(HCAM)多克隆抗体 DAB staining on IHC-P;
    Sample: Mouse Spleen Tissue
    Primary Ab: 10µg/ml Rabbit Anti-Mouse HCAM Antibody
    Control: Used PBS instead of primary antibody
    Second Ab: 2μg/ml HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
    (Catalog: SAA544Rb19)
  • Certificate 通过ISO 9001、ISO 13485质量体系认证

特异性

该抗体是针对HCAM的兔多克隆抗体。在免疫组织化学染色和免疫印迹实验中能识别HCAM。

用法

Western blotting: 0.01-2µg/mL;
Immunohistochemistry: 5-20µg/mL;
Immunocytochemistry: 5-20µg/mL;
Optimal working dilutions must be determined by end user.

储存

经常使用则4°C保存。-20°C保存不超过两年。避免反复冻融。

稳定性

热稳定性以损失率显示。损失率是由加速降解试验决定,具体方法如下:在37°C孵育48小时,没有显著的降解或者沉淀产生。保质期内,在适当的条件下存储,损失率低于5%。

赠品

相关产品

编号 适用物种:Mus musculus (Mouse,小鼠) 应用(仅供研究使用,不用于临床诊断!)
RPA670Mu02 归巢关联细胞黏附分子(HCAM)重组蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
APA670Mu01 归巢关联细胞黏附分子(HCAM)活性蛋白 Cell culture; Activity Assays.
RPA670Mu01 归巢关联细胞黏附分子(HCAM)重组蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
APA670Mu03 归巢关联细胞黏附分子(HCAM)活性蛋白 Cell culture; Activity Assays.
RPA670Mu03 归巢关联细胞黏附分子(HCAM)重组蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
PAA670Mu01 归巢关联细胞黏附分子(HCAM)多克隆抗体 WB; IHC; ICC; IP.
PAA670Mu02 归巢关联细胞黏附分子(HCAM)多克隆抗体 WB; IHC; ICC; IP.
SEA670Mu 归巢关联细胞黏附分子(HCAM)检测试剂盒(酶联免疫吸附试验法) Enzyme-linked immunosorbent assay for Antigen Detection.
LMA670Mu 归巢关联细胞黏附分子(HCAM)等多因子检测试剂盒(流式荧光发光法) FLIA Kit for Antigen Detection.

参考文献

杂志 参考文献
Cancers Predictive Value of Soluble PD-1, PD-L1, VEGFA, CD40 Ligand and CD44 for Nivolumab Therapy in Advanced Non-Small Cell Lung Cancer: A Case-Control Study [Pubmed: 32085544]
留言咨询